6 Results

People

  1. Tap
    Tap
  2. Dickson
    Dickson
  3. Qin
    Qin
  4. D'Angelo
    D'Angelo
  5. Abou-Alfa
    Abou-Alfa
  6. Adrianzen Herrera
    Adrianzen Herrera
  7. Agaram
    Agaram
  8. Antonescu
    Antonescu
  9. Arcila
    Arcila
  10. Cercek Hanjis
    Cercek Hanjis

Groups

  1. Department of Medicine (6)
  2. Sarcoma Service (6)
  3. Solid Tumor Oncology Division (6)
  4. Biostatistics Service (3)
  5. Epidemiology and Biostatistics (3)
  6. GSK Faculty (2)
  7. Hematologic Malignancies, Division of (2)
  8. Tow Center for Developmental Oncology (TCDO) (2)
  9. Body Imaging Service (1)
  10. Breast Medicine Service (1)
  1. "European Journal of Cancer"
  2. "William Tap"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (6)
  2. Sarcoma Service (6)
  3. Solid Tumor Oncology Division (6)
  4. Biostatistics Service (3)
  5. Epidemiology and Biostatistics (3)
  6. GSK Faculty (2)

More Groups

People
  1. William Tap (6)
  2. Li-Xuan Qin (3)
  3. Mark Dickson (3)
  4. Sandra D'Angelo (2)
  5. Agnes Viale (1)
  6. Aimee Crago (1)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2016 (1)
  4. 2015 (1)
  5. 2014 (1)
  6. 2013 (1)
Publications
  1. European Journal of Cancer (6)
Publishers
  1. Elsevier Inc. (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
    Journal Article

    Rosenbaum, E.; Chugh, R.; Ryan, C. W.; Agulnik, M.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial
    Journal Article

    Jones, R. L.; Serrano, C.; von Mehren, M.; George, S.; Heinrich, M. C.; Kang, Y. K.; Schöffski, P.; Cassier, P. A.; Mir, O.; Chawla, S. P.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Detection of IDH1 mutations in circulating free DNA in patients with cholangiocarcinoma
    Meeting Abstract

    Lowery, M. A.; You, D.; Samoila, A.; Peerschke, E.; Viale, A.; Patel, R.; Selcuklu, D.; Rusek, M.; Cercek, A.; Kemeny, N.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas
    Journal Article

    Gounder, M.; Desai, V.; Kuk, D.; Agaram, N.; Arcila, M.; Durham, B.; Keohan, M. L.; Dickson, M. A.; D'Angelo, S. P.; Shukla, N.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • A first-in-human (FIH) safety and pharmacological study of SAR405838, a novel HDM2 antagonist, in patients with solid malignancies
    Meeting Abstract

    de Weger, V.; Lolkema, M. P.; Dickson, M.; Le Cesne, A.; Wagner, A.; Merqui-Roelvink, M.; Varga, A.; Tap, W.; Schwartz, G.; Demetri, G.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Final results of sequential phase 2 studies of palbociclib (PD0332991) in CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M.; Tap, W. D.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Crago, A. M.; Singer, S.; Schwartz, G. K.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save